Invention Grant
US08614206B2 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
有权
吡唑-4-基 - 杂环基甲酰胺化合物及其使用方法
- Patent Title: Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
- Patent Title (中): 吡唑-4-基 - 杂环基甲酰胺化合物及其使用方法
-
Application No.: US13627262Application Date: 2012-09-26
-
Publication No.: US08614206B2Publication Date: 2013-12-24
- Inventor: Alastair James Hodges , Mizio Matteucci , Andrew Sharpe , Minghua Sun , Xiaojing Wang , Vickie H. Tsui
- Applicant: Genentech, Inc.
- Applicant Address: CH Basel
- Assignee: F. Hoffmann-La Roche AG
- Current Assignee: F. Hoffmann-La Roche AG
- Current Assignee Address: CH Basel
- Agency: Genentech, Inc.
- Agent Alex Andrus
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61K31/44 ; A61K31/415 ; A01N43/40 ; A01N43/56 ; C07D401/00 ; C07D403/00 ; C07D403/02

Abstract:
Pyrazol-4-yl-heterocyclyl-carboxamide compounds of Formula I, including stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, wherein X is thiazolyl, pyrazinyl, pyridinyl, or pyrimidinyl, are useful for inhibiting Pim kinase, and for treating disorders such as cancer mediated by Pim kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Public/Granted literature
- US20130079321A1 PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE Public/Granted day:2013-03-28
Information query